Eikonizo Therapeutics
PrivateLast Round
Corporate Funding
Dec 10, 2024
Total Funding Raised
$1.4M
Momentum Score
25 /100
Company Overview
Eikonizo Therapeutics is a biotechnology company focused on developing small molecule therapeutic drugs aimed at treating neurodegenerative diseases through innovative gene therapy techniques.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eikonizo Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Eikonizo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 10, 2024 | ||||
| Grant | Mar 4, 2020 | ||||
| Grant | Apr 1, 2018 |
Eikonizo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rainwater Charitable Foundation | Grant |
| Alzheimer's Association | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 508% MoM, reaching 772.
Eikonizo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eikonizo Therapeutics's valuation, stock price, and market status.
